A RELATIVELY HIGH-FREQUENCY OF SEVERE (TYPE-III) VONWILLEBRANDS DISEASE IN ISRAEL

被引:40
作者
BERLINER, SA
SELIGSOHN, U
ZIVELIN, A
ZWANG, E
SOFFERMAN, G
机构
[1] ICHILOV HOSP, TEL AVIV MED CTR, INST HAEMATOL, 6 WEIZMAN ST, IL-64239 TEL AVIV, ISRAEL
[2] TEL AVIV UNIV, SACKLER SCH MED, TEL AVIV, ISRAEL
关键词
D O I
10.1111/j.1365-2141.1986.tb02966.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sixty patients with von Willebrand''s disease belonging to 34 unrelated families were classified into the various types of the disease by analysis of the multimer patterns of von Willebrand factor. Type I disease was observed in 62% of the families, a finding similar to the recently published British and Swedish series of patients. Type III (severe) on Willebrand''s disease was observed more frequently in the Israeli group (29%) than in the other two series. Of the 16 patients with type III disease eight were Arabs living in Israel, the West Bank and the Gaza Strip (total population about 1.5 .times. 106). Thus, it appears that the frequency of type III disease is very high among Arabs (5.3/106). Sibship analysis of all families affected by the type III mutant gene was compatible with an autosomal recessive mode of inheritance. An attempt was made to define carriers of type III disease and to distinguish them from type I patients and from healthy subjects. In 15 obligate carriers of type III disease mean levels of factor VIII clotting activity, of von Willebrand factor and of ristocetin cofactor were significantly higher than the corresponding mean values observed in 31 symptomatic and 12 asymptomatic type I patients, and in turn significantly lower than the corresponding mean values observed in 30 healthy subjects. Ristocetin cofator was the best criterion for discrimination among carriers of type III disease, normal subjects and type I patients.
引用
收藏
页码:535 / 543
页数:9
相关论文
共 26 条
[1]   APPARENT DOMINANT AND RECESSIVE INHERITANCE OF VON-WILLEBRANDS DISEASE WITHIN THE SAME KINDREDS - POSSIBLE BIOCHEMICAL-MECHANISMS [J].
BLOOM, AL ;
PEAKE, IR .
THROMBOSIS RESEARCH, 1979, 15 (3-4) :505-512
[2]   ANALYSIS OF THE COMPLEXITY OF THE MULTIMERIC STRUCTURE OF FACTOR-VIII RELATED ANTIGEN VONWILLEBRAND PROTEIN USING A MODIFIED ELECTROPHORETIC TECHNIQUE [J].
ENAYAT, MS ;
HILL, FGH .
JOURNAL OF CLINICAL PATHOLOGY, 1983, 36 (08) :915-919
[3]   VONWILLEBRAND-FACTOR MULTIMER PATTERNS IN VONWILLEBRANDS DISEASE [J].
HOYER, LW ;
RIZZA, CR ;
TUDDENHAM, EGD ;
CARTA, CA ;
ARMITAGE, H ;
ROTBLAT, F .
BRITISH JOURNAL OF HAEMATOLOGY, 1983, 55 (03) :493-507
[4]  
INGRAM GIC, 1978, LANCET, V2, P1364
[5]  
LARRIEU M J, 1953, Rev Hematol, V8, P361
[6]   ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS [J].
LAURELL, CB .
ANALYTICAL BIOCHEMISTRY, 1965, 10 (02) :358-&
[7]   DIAGNOSIS OF VON WILLEBRANDS DISEASE - COMPARATIVE-STUDY OF DIAGNOSTIC TESTS ON 9 FAMILIES WITH VONWILLEBRANDS DISEASE AND ITS DIFFERENTIAL-DIAGNOSIS FROM HEMOPHILIA AND THROMBOCYTOPATHY [J].
LIAN, ECY ;
DEYKIN, D .
AMERICAN JOURNAL OF MEDICINE, 1976, 60 (03) :344-356
[8]   METHOD FOR ASSAYING VON WILLEBRAND FACTOR (RISTOCETIN COFACTOR) [J].
MACFARLANE, DE ;
STIBBE, J ;
KIRBY, EP ;
ZUCKER, MB ;
GRANT, RA ;
MCPHERSON, J .
THROMBOSIS ET DIATHESIS HAEMORRHAGICA, 1975, 34 (01) :306-308
[9]   ATHEROSCLEROSIS AND VONWILLEBRAND-FACTOR 9U. PREVALENCE OF SEVERE VONWILLEBRANDS DISEASE IN WESTERN-EUROPE AND ISRAEL [J].
MANNUCCI, PM ;
BLOOM, AL ;
LARRIEU, MJ ;
NILSSON, IM ;
WEST, RR .
BRITISH JOURNAL OF HAEMATOLOGY, 1984, 57 (01) :163-169
[10]  
MCKUSICK VA, 1969, HUMAN GENETICS